BioSpace News Archive

Takeda Canada Inc. is pleased to announce that effective January 31, Ontario will publicly reimburse INTUNIV XR® (guanfacine hydrochloride extended-release tablets) for the treatment of attention deficit/hyperactivity disorder (ADHD) symptoms in children and adolescents (6 to 17 years old) in the following settings

The Washington Area Hyundai Dealers, The Washington Auto Show, Georgetown Lombardi Comprehensive Cancer Center, and Children’s National Hospital are teaming up to help fight pediatric cancer through the Hyundai Hands On Hope Contest at the 2020 Washington Auto Show.

Unprofessional physician behaviors can result in serious consequences including decreased physician and staff productivity, increased staff turnover and adverse patient outcomes

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Epizyme to be the exclusive specialty pharmacy partner for TAZVERIK™ (Tazemetostat), a new oral treatment for adult and pediatric patients (aged 16 years and older) with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

Labii, a Bay Area Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) company, is excited to announce a new partnership with MBC BioLabs...

China SXT Pharmaceuticals, Inc. announced that it will be increasing its production of its entire TCM product line, in response to recent Chinese government pronouncements signaling a large expansion of the role and use of TCMPs in the Chinese health care system.

Lexicon Pharmaceuticals, Inc., announced real-world data on XERMELO’s® antiproliferative effects in patients with carcinoid syndrome that were presented at the American Society for Clinical Oncology 2020 Symposium.

Genentech, a member of the Roche Group, announced that the Phase III IMvigor010 study evaluating Tecentriq® as an adjuvant monotherapy treatment did not meet its primary endpoint of disease-free survival compared to observation in people with muscle-invasive urothelial cancer.

PEAK Matrix Clinical and Care Management Analysis Positions Cognizant in Top Category for Its Solutions that Improve Affordable Care for Millions

Eli Lilly and Company (NYSE: LLY) announced today that Anat Hakim will join the company on February 3, 2020 as senior vice-president and general counsel.